Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries
For more information on this project, please contact the EU PE&PV research network at eupepv@uu.nl.
Project information
- EU PE&PV research network
- EUPAS47725
- Specific Contract 01 implementing Framework service contract EMA/2020/46/TDA/L5.06
Full title
Effectiveness of heterologous and booster Covid-19 vaccination in 5 European countries, using a cohort approach in children and adults with a full primary Covid-19 vaccination regimen (CoVE)
Principal investigator
Dr. Elisa Martín Merino, Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
Participating organisations
- Utrecht University, The Netherlands - consortium lead
- AEMPS, Spain - coordinator
- UMC Utrecht, The Netherlands
- VAC4EU, Belgium
- Democritus University of Thrace, Greece
- APHP, France
- ARS, Italy
- INSPIRE, Italy
- SoSeTe-Pedianet, Italy
- Rīga Stradiņš University, Latvia
- PHARMO Institute, The Netherlands
- RIVM, The Netherlands
- IACS, Spain
- IDIAPJGol, Spain
- RTI Health Solutions, Spain
- Servicio Navarro de Salud, Spain
- Teamit Institute, Spain
- DSRU, UK
Status
Completed (2023)
Deliverables
Peer-reviewed scientific publications
- Effectiveness of homologous/heterologous booster COVID-19 vaccination schedules against severe illness in general population and clinical subgroups in three European countries. Riefolo F, Castillo-Cano B, Martín-Pérez M, Messina D, Elbers R, Brink-Kwakkel D, Villalobos F, Ingrasciotta Y, Garcia-Poza P, Swart-Polinder K, Souverein P, Saiz LC, Bissacco CA, Leache L, Tari M, Crisafulli S, Grimaldi L, Vaz T, Gini R, Klungel O, Martín-Merino E. Vaccine. 2023 Nov 13;41(47):7007-7018. doi: 10.1016/j.vaccine.2023.10.011. Epub 2023 Oct 17. PMID: 37858451.
- Impact and Effectiveness of COVID-19 mRNA Vaccination Against COVID-19 Hospitalisation in Paediatrics: A Cohort Study Using Two Linked Data Sources in Spain. Castillo-Cano B, Riefolo F, Villalobos F, Martín-Pérez M, Messina D, Elbers R, Brink-Kwakkel D, Bissacco CA, Segundo E, Saiz LC, Leache L, Barbieri E, Vaz T, Gini R, Klungel O, Martín-Merino E. Pharmacoepidemiol Drug Saf. 2025 Nov;34(11):e70239. doi: 10.1002/pds.70239. PMID: 41125425; PMCID: PMC12544726.